CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,614.10
+7.40 (0.46%)
At close: Feb 12, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 98.72 billion as of February 13, 2026.
Market Cap
98.72B
Enterprise Value
98.81B
Revenue
13.44B
Ranking
n/a
PE Ratio
57.61
Stock Price
1,614.10
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 98.72B, an increase of 12.21%. That is a compound annual growth rate of 104.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 98.72B | 16.55% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 304.50B |
| AstraZeneca Pharma India | 226.77B |
| Jubilant Pharmova | 148.72B |
| Granules India | 140.43B |
| Caplin Point Laboratories | 131.67B |
| Rubicon Research | 128.62B |
| Sanofi India | 93.46B |
| Procter & Gamble Health | 91.08B |